PT3067068T - Sodium meta arsenite for use in the treatment of multiple myeloma - Google Patents
Sodium meta arsenite for use in the treatment of multiple myelomaInfo
- Publication number
- PT3067068T PT3067068T PT161624143T PT16162414T PT3067068T PT 3067068 T PT3067068 T PT 3067068T PT 161624143 T PT161624143 T PT 161624143T PT 16162414 T PT16162414 T PT 16162414T PT 3067068 T PT3067068 T PT 3067068T
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- multiple myeloma
- sodium meta
- meta arsenite
- arsenite
- Prior art date
Links
- 208000034578 Multiple myelomas Diseases 0.000 title 1
- 206010035226 Plasma cell myeloma Diseases 0.000 title 1
- PTLRDCMBXHILCL-UHFFFAOYSA-M sodium arsenite Chemical compound [Na+].[O-][As]=O PTLRDCMBXHILCL-UHFFFAOYSA-M 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2005076071 | 2005-05-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3067068T true PT3067068T (en) | 2019-11-20 |
Family
ID=53838100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT161624143T PT3067068T (en) | 2005-05-09 | 2006-05-09 | Sodium meta arsenite for use in the treatment of multiple myeloma |
Country Status (2)
| Country | Link |
|---|---|
| HK (1) | HK1201043A1 (en) |
| PT (1) | PT3067068T (en) |
-
2006
- 2006-05-09 PT PT161624143T patent/PT3067068T/en unknown
-
2012
- 2012-02-22 HK HK15101384.5A patent/HK1201043A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1201043A1 (en) | 2015-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE046029T2 (en) | Sodium meta arsenite for use in the treatment of multiple myeloma | |
| HUE040060T2 (en) | Halogen-substituted boronophthalides for the treatment of infections | |
| IL186616A (en) | Spiro-oxindole compounds and their use as therapeutic agents | |
| IL186408A0 (en) | Combination treatment methods | |
| EP2079313A4 (en) | Antimicrobial and antiviral compounds and methods for their use | |
| EP1928453A4 (en) | Methods and compositions for the preventioin and treatment of kidney disease | |
| GB0512940D0 (en) | Compounds and their use | |
| IL194899A0 (en) | Amino-ethyl-amino-aryl (aeaa) compounds and their use | |
| GB0520743D0 (en) | Compounds and their use | |
| PL1945243T3 (en) | Use of calcitonin for the treatment of ra | |
| PT2392335E (en) | Use of 24-norudca | |
| GB2432157B (en) | Letrozole purification process | |
| GB0516068D0 (en) | Well treatment | |
| GB0525540D0 (en) | New treatment | |
| GB0511769D0 (en) | Treatment | |
| ZA200800515B (en) | New Salt I | |
| PT1962913E (en) | Radioimmunoconjugate for human cd66 for the treatment of multiple myeloma | |
| PT3067068T (en) | Sodium meta arsenite for use in the treatment of multiple myeloma | |
| GB0502171D0 (en) | Well treatment | |
| HUP0500947A2 (en) | Composition for treatment of paradontosis | |
| GB0516610D0 (en) | Compounds for use in therapy | |
| GB0510814D0 (en) | Compounds for use in therapy | |
| GB0510815D0 (en) | Compounds for use in therapy | |
| GB0515900D0 (en) | Compounds for use in therapy | |
| GB0521278D0 (en) | Compounds and their use |